Developing a Cell-Based Matrix Approach for AAV Gene Therapy
Time: 9:30 am
day: Day 1
Details:
- Understanding the variability of TCID50
- Optimizing a function potency assay: challenges and lessons learned
- Incorporating a protein expression assay into a potency strategy during product development
